-
公开(公告)号:US11866762B2
公开(公告)日:2024-01-09
申请号:US17240093
申请日:2021-04-26
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Aye Aye Khine , Tino Alavie , Stephen Wesley Leonard
CPC classification number: C12Q1/18 , C12Q1/689 , C12Q2600/106 , C12Q2600/158
Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
-
公开(公告)号:US20210246483A1
公开(公告)日:2021-08-12
申请号:US17240093
申请日:2021-04-26
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Aye Aye Khine , Tino Alavie , Stephen Wesley Leonard
Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
-
公开(公告)号:US10988794B2
公开(公告)日:2021-04-27
申请号:US16280842
申请日:2019-02-20
Applicant: Qvella Corporation
Inventor: Samad Talebpour , Aye Aye Khine , Tino Alavie , Stephen Wesley Leonard
Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
-
公开(公告)号:US12247197B2
公开(公告)日:2025-03-11
申请号:US18012433
申请日:2021-06-25
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Anna Khimchenko , Maryam Asadishekari , Stephen Wesley Leonard
IPC: G06K9/62 , C12N1/20 , G02B21/36 , G06T5/50 , G06T5/70 , G06V10/147 , G06V10/774 , G06V10/82 , G06V20/69
Abstract: Systems and methods are provided for classifying microbial cells according to morphological features of microcolonies. A dark-field objective is employed to acquire a dark-field image of a microcolony during a microcolony growth phase that is characterized by phenotypic expression of microcolony morphological features which evolve with time and are differentiated among classes of microbial cell types. The dark-field image is processed to classify the microcolony according to two or more microbial cell types, such as Gram status and/or speciation. The dark-field objective may have a numerical aperture selected to facilitate the imaging of microcolony morphological features, residing, for example, between 0.15 and 0.35. A set of dark-field images of a microcolony may be collected during the microcolony growth phase and processed to classify the microcolony. Classification may be performed according to a temporal ordering of the dark-field images, for example, using a recurrent neural network.
-
公开(公告)号:US11738343B2
公开(公告)日:2023-08-29
申请号:US17338856
申请日:2021-06-04
Applicant: QVELLA CORPORATION
Inventor: Robert Maaskant , Sanjesh Yasotharan , Samad Talebpour , Stephen W. Leonard , Cyrus Etemad-Moghadam , Alexander Zahn
IPC: B01L3/00 , B01L7/00 , B04B5/04 , B04B13/00 , B01D19/00 , B01D17/02 , F16K7/00 , B01D21/26 , C12N15/00 , F16K99/00 , C12N15/10
CPC classification number: B01L3/502753 , B01D17/0217 , B01D19/0052 , B01D21/262 , B01L3/5021 , B01L3/502715 , B01L3/502738 , B01L7/52 , B04B5/0407 , B04B5/0421 , B04B13/00 , C12N15/1003 , F16K7/00 , F16K99/0015 , B01L2200/027 , B01L2200/0684 , B01L2200/10 , B01L2300/0816 , B01L2300/0887 , B01L2300/1822 , B01L2300/1827 , B01L2300/1844 , B01L2400/0409 , B01L2400/0487 , B01L2400/0655 , F16K2099/0084
Abstract: Systems, methods and devices are provided for the automated centrifugal processing of samples. In some embodiments, an integrated fluidic processing cartridge is provided, in which a centrifugation chamber is fluidically interfaced, through a lateral surface thereof, with a microfluidic device, and wherein the integrated fluidic processing cartridge is configured to be inserted into a centrifuge for centrifugation. A cartridge interfacing assembly may be employed to interface with the integrated fluidic processing cartridge for performing various fluidic processing steps, such as controlling the flow of fluids into and out of the centrifugation chamber, and controlling the flow of fluids into the microfluidic device, and optionally for the further fluidic processing of fluids extracted to the microfluidic device. The integrated fluidic processing cartridge may include a supernatant chamber the extraction of a supernatant thereto, and a diluent chamber for diluting a suspension collected in the centrifugation chamber.
-
公开(公告)号:US11371988B2
公开(公告)日:2022-06-28
申请号:US14735917
申请日:2015-06-10
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Aye Aye Khine , Stephen W Leonard , Robert Maaskant , Tino Alavie
IPC: G01N33/543 , B01L3/00 , C12M3/06 , C12M1/12 , C12M1/00 , C12M1/42 , C12M1/34 , C12N1/06 , C12N11/14 , C12N13/00 , G01N33/50
Abstract: The present invention provides a microfluidic devices and methods of use thereof for the concentration and capture of cells. A pulsed non Faradaic electric field is applied relative to a sample under laminar flow, which results to the concentration and capture of charged analyte. Advantageously, pulse timing is selected to avoid problems associated with ionic screening within the channel. At least one of the electrodes within the channel is coated with an insulating layer to prevent a Faradaic current from flowing in the channel. Under pulsed application of a unipolar voltage to the electrodes, charged analyte within the sample is moved towards one of the electrodes via a transient electrophoretic force.
-
公开(公告)号:US11027279B2
公开(公告)日:2021-06-08
申请号:US16818095
申请日:2020-03-13
Applicant: QVELLA CORPORATION
Inventor: Robert Maaskant , Sanjesh Yasotharan , Samad Talebpour , Stephen W. Leonard , Cyrus Etemad-Moghadam , Alexander Zahn
IPC: B01L3/00 , B01L7/00 , B04B5/04 , B04B13/00 , B01D19/00 , B01D17/02 , F16K7/00 , B01D21/26 , C12N15/10 , F16K99/00
Abstract: Systems, methods and devices are provided for the automated centrifugal processing of samples. In some embodiments, an integrated fluidic processing cartridge is provided, in which a centrifugation chamber is fluidically interfaced, through a lateral surface thereof, with a microfluidic device, and wherein the integrated fluidic processing cartridge is configured to be inserted into a centrifuge for centrifugation. A cartridge interfacing assembly may be employed to interface with the integrated fluidic processing cartridge for performing various fluidic processing steps, such as controlling the flow of fluids into and out of the centrifugation chamber, and controlling the flow of fluids into the microfluidic device, and optionally for the further fluidic processing of fluids extracted to the micro-fluidic device. The integrated fluidic processing cartridge may include a supernatant chamber the extraction of a supernatant thereto, and a dilutent chamber for diluting a suspension collected in the centrifugation chamber.
-
公开(公告)号:US20190177766A1
公开(公告)日:2019-06-13
申请号:US16280842
申请日:2019-02-20
Applicant: Qvella Corporation
Inventor: Samad Talebpour , Aye Aye Khine , Tino Alavie , Stephen Wesley Leonard
Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
-
公开(公告)号:US09574245B2
公开(公告)日:2017-02-21
申请号:US13750723
申请日:2013-01-25
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Aye Aye Khine , Robert Maaskant , Tino Alavie
CPC classification number: C12Q1/6806 , B01L3/502715 , B01L3/502738 , B01L3/502753 , B01L7/52 , B01L2200/0631 , B01L2200/143 , B01L2300/0645 , B01L2300/0681 , B01L2300/0809 , B01L2300/0858 , B01L2300/087 , B01L2300/0874 , B01L2300/0887 , B01L2300/14 , B01L2300/1833 , B01L2400/0694 , C12M35/02 , C12M47/06 , C12N1/066 , C12N1/08 , C12N13/00 , C12Q1/686 , C12Q3/00
Abstract: Devices and methods are provided for electrically lysing cells and releasing macromolecules from the cells. A microfluidic device is provided that includes a planar channel having a thickness on a submillimeter scale, and including electrodes on its upper and lower inner surfaces. After filling the channel with a liquid, such that the channel contains cells within the liquid, a series of voltage pulses of alternating polarity are applied between the channel electrodes, where the amplitude of the voltage pulses and a pulsewidth of the voltage pulses are effective for causing irreversible electroporation of the cells. The channel is configured to possess thermal properties such that the application of the voltage produces a rapid temperature rise as a result of Joule heating for releasing the macromolecules from the electroplated cells. The channel may also include an internal filter for capturing and concentrating the cells prior to electrical processing.
Abstract translation: 提供了用于电解裂解细胞并从细胞释放大分子的装置和方法。 提供一种微流体装置,其包括具有亚毫米级厚度的平面通道,并且在其上下表面上包括电极。 在用液体填充通道之后,使得通道在液体内包含单元,在通道电极之间施加一系列交替极性的电压脉冲,其中电压脉冲的幅度和电压脉冲的脉冲宽度对于 引起细胞的不可逆电穿孔。 该通道被配置为具有热性质,使得施加电压由于焦耳加热而导致快速升温,以从电镀细胞释放大分子。 通道还可以包括内部滤波器,用于在电处理之前捕获和集中单元。
-
10.
公开(公告)号:US20160138072A1
公开(公告)日:2016-05-19
申请号:US14901200
申请日:2014-07-03
Applicant: QVELLA CORPORATION
Inventor: Samad Talebpour , Aye Aye Khine , Tino Alavie , Stephen Wesley Leonard
CPC classification number: C12Q1/18 , C12Q1/689 , C12Q2600/106 , C12Q2600/158
Abstract: Methods are provided for performing antibotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the pressence of a selected antibiotic and a stimulus is provided to induce the production on m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
Abstract translation: 提供了基于在暴露于抗生素后从微生物细胞中检测RNA(例如tmRNA)进行抗生素敏感性测试的方法。 在一些实施方案中,从样品获得等分试样,其中一个样品含有选定的抗生素。 包括生长培养基在内的等分试样在适合于微生物生长的条件下孵育,并除去每个等分试样中的微生物细胞并裂解,并将裂解物进行逆转录和扩增,推断所选抗生素对微生物的作用 细胞。 在一个实施方案中,将含有微生物细胞的样品在所选择的抗生素的压力下孵育,并提供刺激以诱导在微生物细胞内的m RNA上产生。 随后裂解微生物细胞,而不会在裂解物中明显降解m RNA,并检测m RNA以确定抗生素对微生物细胞的作用。
-
-
-
-
-
-
-
-
-